8-KShareholder MattersExhibits & Filings

COPART INC 8-K Report, Rights Modification (Mar 15, 2006)

Filed March 15, 2006For Securities:CPRT

Summary

Copart, Inc. (CPRT) filed a Form 8-K on March 15, 2006, reporting a material modification to its Preferred Stock Rights Agreement. The primary change involves an amendment to the exercise price of the rights associated with its Series A Participating Preferred Stock. This amendment, effective March 14, 2006, adjusts the exercise price to $120.48 per one-one thousandth of a share. This action is likely a technical adjustment to maintain the effectiveness and intended function of the company's poison pill, potentially in response to market conditions or other corporate events, though the filing itself does not elaborate on the specific triggers. For investors, this filing primarily indicates a procedural update to the company's shareholder rights plan. The change in exercise price, while specific, is not inherently positive or negative without further context on the company's strategic rationale or stock performance. Investors should monitor any future filings for explanations of why this adjustment was made and consider its implications in conjunction with Copart's overall business performance and market strategy.

Key Highlights

  • 1Copart, Inc. filed an 8-K on March 15, 2006, effective March 14, 2006.
  • 2The filing reports a material modification to the Company's Preferred Stock Rights Agreement.
  • 3The exercise price of a right to purchase one-one thousandth of a share of Series A Participating Preferred Stock has been amended.
  • 4The new exercise price is set at $120.48 per one-one thousandth of a share.
  • 5Certain conforming changes related to the exercise price adjustment were also made.
  • 6This amendment is an adjustment to the company's shareholder rights plan, commonly known as a 'poison pill'.

Frequently Asked Questions

The main purpose of this 8-K filing is to report a material modification to Copart, Inc.'s Preferred Stock Rights Agreement. Specifically, it details an amendment to the exercise price of the associated stock rights.

The exercise price for the right to purchase one-one thousandth of a share of Copart's Series A Participating Preferred Stock was amended to $120.48. Conforming changes related to this price adjustment were also made.

A Preferred Stock Rights Agreement, often referred to as a 'poison pill,' is a defensive measure designed to prevent hostile takeovers. Modifying the exercise price is a common procedural update that might be triggered by market events, stock price fluctuations, or as part of maintaining the plan's effectiveness and intended deterrent against unsolicited acquisition attempts. The specific reason for this particular change is not detailed in this filing.

This filing primarily represents a technical adjustment to a shareholder rights plan and does not typically have a direct or immediate impact on Copart's stock price or the value of existing common shares. The change in exercise price is intended to maintain the functionality of the rights plan, not to directly alter shareholder equity or trading dynamics.